Supriya Lifescience standalone net profit declines 4.74% in the March 2022 quarter

20 May 2022 , 05:38 PM

Net profit of Supriya Lifescience declined 4.74% to Rs 46.21 crore in the quarter ended March 2022 as against Rs 48.51 crore during the previous quarter ended March 2021. Sales rose 37.21% to Rs 181.27 crore in the quarter ended March 2022 as against Rs 132.11 crore during the previous quarter ended March 2021. For the full year,net profit rose 22.83% to Rs 151.81 crore in the year ended March 2022 as against Rs 123.59 crore during the previous year ended March 2021. Sales rose 35.48% to Rs 530.05 crore in the year ended March 2022 as against Rs 391.25 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	181.27	132.11	37	530.05	391.25	35
OPM %	41.50	50.84	–	40.37	44.26	–
PBDT	78.07	67.43	16	217.37	174.07	25
PBT	75.49	65.65	15	207.25	167.31	24
NP	46.21	48.51	-5	151.81	123.59	23

Powered by Capital Market – Live News